Who Paid My Doc
Anna Walding
Hospice and Palliative Medicine Dothan, AL Medical Doctor
NPI 1467602854 CMS profile 490672
106 Mayfield Ct, Dothan, AL 36305
General payments
$370,869
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Anna Walding of Dothan, AL is reported in the CMS Open Payments database as having received $370,869 across 565 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 99th percentile of Hospice and Palliative Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
6 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $61 | 3 | |
| 2024 | General | $21,804 | 34 | |
| 2023 | General | $109,214 | 135 | |
| 2022 | General | $90,471 | 135 | |
| 2021 | General | $78,018 | 140 | |
| 2020 | General | $71,302 | 118 |
Beside peers
- Anna Walding
- Hospice and Palliative Medicine median
- Middle half of Hospice and Palliative Medicine
- National median
In program year 2025, general payments to Anna Walding were reported at $61. Among 378 Hospice and Palliative Medicine profiles paid that year, the median was $78 and the middle half received between $28 and $160.
Show as a table
| Year | Anna Walding | Hospice and Palliative Medicine median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $80 | $22–$147 | $163 |
| 2020 | $71,302 | $36 | $18–$121 | $114 |
| 2021 | $78,018 | $64 | $23–$194 | $132 |
| 2022 | $90,471 | $67 | $22–$158 | $149 |
| 2023 | $109,214 | $65 | $25–$149 | $160 |
| 2024 | $21,804 | $75 | $25–$158 | $164 |
| 2025 | $61 | $78 | $28–$160 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 1 drugPart D claims
18
Drug cost
$280
Branded share of claims
100%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Ondansetron Odt Ondansetron | Brand | 18 | $280 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 104,182 Part D prescribers listed as Internal Medicine; they describe a distribution and say nothing about conduct.
Records
565 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Hospice and Palliative Medicine in Alabama
Kristy Johnson-Pich
Hospice and Palliative Medicine · Dothan, AL
Neal Steil
Hospice and Palliative Medicine · Cullman, AL
Donato Dumlao
Hospice and Palliative Medicine · Daphne, AL
Hesham Hassan
Hospice and Palliative Medicine · Fultondale, AL
Kevin Barley
Hospice and Palliative Medicine · Huntsville, AL
Echo Osland
Hospice and Palliative Medicine · Huntsville, AL
Related records
Hospice and Palliative Medicine in Alabama
Practitioners in the same specialty and state, ranked by reported value.
All Hospice and Palliative Medicine
Everyone recorded under this specialty, nationwide.
Doctors in Alabama
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.